Biomea Fusion, Inc.

NasdaqGS:BMEA Stock Report

Market Cap: US$91.2m

Biomea Fusion Management

Management criteria checks 2/4

Biomea Fusion's CEO is Mick Hitchcock, appointed in Mar 2025, has a tenure of less than a year. directly owns 0.16% of the company’s shares, worth $148.35K. The average tenure of the management team and the board of directors is 4.7 years and 1.9 years respectively.

Key information

Mick Hitchcock

Chief executive officer

US$241.5k

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.2%
Management average tenure4.7yrs
Board average tenure1.9yrs

Recent management updates

Recent updates

Biomea Fusion: Surging On Data, Sinking On Funding - I'm On The Sidelines

Oct 07

Can Biomea Fusion (NASDAQ:BMEA) Afford To Invest In Growth?

Aug 17
Can Biomea Fusion (NASDAQ:BMEA) Afford To Invest In Growth?

We're Keeping An Eye On Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate

Sep 30
We're Keeping An Eye On Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate

We Think Biomea Fusion (NASDAQ:BMEA) Needs To Drive Business Growth Carefully

Jun 10
We Think Biomea Fusion (NASDAQ:BMEA) Needs To Drive Business Growth Carefully

We Think Biomea Fusion (NASDAQ:BMEA) Can Afford To Drive Business Growth

Feb 22
We Think Biomea Fusion (NASDAQ:BMEA) Can Afford To Drive Business Growth

Is Biomea Fusion (NASDAQ:BMEA) In A Good Position To Invest In Growth?

Nov 07
Is Biomea Fusion (NASDAQ:BMEA) In A Good Position To Invest In Growth?

We Think Biomea Fusion (NASDAQ:BMEA) Needs To Drive Business Growth Carefully

Jul 12
We Think Biomea Fusion (NASDAQ:BMEA) Needs To Drive Business Growth Carefully

Here's Why We're Not Too Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Situation

Mar 29
Here's Why We're Not Too Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Situation

We're Hopeful That Biomea Fusion (NASDAQ:BMEA) Will Use Its Cash Wisely

Nov 03
We're Hopeful That Biomea Fusion (NASDAQ:BMEA) Will Use Its Cash Wisely

CEO

Mick Hitchcock (75 yo)

less than a year
Tenure
US$241,496
Compensation

Dr. Michael J. M. Hitchcock, Ph D., also known as Mick, is Business Advisor Sarcomatrix Therapeutics, Corp. Dr. Hitchcock serves as Director at Click Bio Inc. He has been a Director at Biomea Fusion, Inc....

Leadership Team

NamePositionTenureCompensationOwnership
Michael J. Hitchcock
Interim CEO & Directorless than a yearUS$241.50k0.16%
$ 148.3k
Ramses Erdtmann
Co-Founder8.3yrsUS$1.98m2.96%
$ 2.7m
Heow Tan
Chief Technology & Quality Officer5.1yrsno datano data
Thorsten Kirschberg
Executive Vice President of Research5.3yrsno datano data
Stephan Morris
Chief Development Officer3.8yrsno datano data
Ravi Upasani
Executive Vice President of Intellectual Property4.7yrsno datano data
Caroline Perez- Dupont
Senior Vice President of Contracts1.9yrsno datano data
4.7yrs
Average Tenure
64yo
Average Age

Experienced Management: BMEA's management team is considered experienced (4.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Michael J. Hitchcock
Interim CEO & Director4.8yrsUS$241.50k0.16%
$ 148.3k
Ramses Erdtmann
Co-Founder8.3yrsUS$1.98m2.96%
$ 2.7m
Eric Aguiar
Independent Lead Director5yrsUS$255.00k0.00028%
$ 255.4
Juliana Chan
Member of Scientific Advisory Board1.2yrsno datano data
Elizabeth Faust
Independent Director3.5yrsUS$224.00k0%
$ 0
Sumita Ray
Independent Director4.5yrsUS$235.50k0%
$ 0
Julio Rosenstock
Member of Scientific Advisory Board1.2yrsno datano data
Jeremy Pettus
Member of Scientific Advisory Board1.9yrsno datano data
Rohit Kulkarni
Co-Chair of Scientific Advisory Board1.9yrsno datano data
Juan Frias
Co-Chair of Scientific Advisory Boardless than a yearUS$4.17m0.00049%
$ 446.9
Mohamed Hassanein
Member of Scientific Advisory Board1.2yrsno datano data
Freddy Eliaschewitz
Member of Scientific Advisory Board1.2yrsno datano data
1.9yrs
Average Tenure
62yo
Average Age

Experienced Board: BMEA's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/26 03:36
End of Day Share Price 2025/12/26 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Biomea Fusion, Inc. is covered by 15 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Naureen QuibriaCapital One Securities, Inc.
Yigal NochomovitzCitigroup Inc
Jason KolbertD. Boral Capital LLC.